The data were compatible with no effect of any of the peptides on AFP release from cultured HepG2 cells (Supplementary Fig. S5), suggesting that iRGD did not affect constitutive secretion of AFP from HCC cells. The gene discussed is AFP; the disease is hepatocellular carcinoma.